Verona Pharma PLC Q1 2022 Earnings Call Transcript - Thomson StreetEvents

Verona Pharma PLC Q1 2022 Earnings Call Transcript

Verona Pharma PLC Q1 2022 Earnings Call Transcript - Thomson StreetEvents
Verona Pharma PLC Q1 2022 Earnings Call Transcript
Published May 03, 2022
10 pages (5854 words) — Published May 03, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of VRNA.OQ earnings conference call or presentation 3-May-22 1:00pm GMT

  
Brief Excerpt:

...Operator Welcome to Verona Pharma's First Quarter 2020 Financial Results and Operating Highlights Conference Call. (Operator Instructions) Earlier this morning, Verona Pharma issued a press release announcing its financial results for the 3 months ended March 31, 2022. A copy can be found in the Investor Relations tab on the corporate website, www.veronapharma.com. Before we begin, I'd like to remind you that during today's call, statements about the company's future expectations, plans and prospects are forward-looking statements. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking statements, including, without limitation, the impact of the COVID-19 pandemic and the Russia-Ukraine...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Verona Pharma PLC
Ticker
VRNA.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Andreas Argyrides - Wedbush Securities Inc., Research Division - Analyst : Just 2 for us here. So even though the Phase III is not evaluating ensifentrine for COPD exacerbations. Of the COPD patients who remain symptomatic on current therapies, are there any phenotypes that you anticipate will be the most responsive ensifentrine based on the data that you guys have generated so far? And then if the 3 mg ensifentrine shows a greater effect on FEV1, but less of an impact on symptoms, what impact would this have could have on the commercial uptake? Or any color on that?

Question: Andreas Argyrides - Wedbush Securities Inc., Research Division - Analyst : Looking forward to the Investor Day.

Question: Edward Hamilton Nash - Canaccord Genuity Corp., Research Division - Analyst : I want to just ask, now that we're getting closer now to getting these 2 Phase III readouts and NDA filing at the beginning of next year. Just wanted to kind of understand what's going to be happening, I guess, towards maybe the end of this year or beginning of next year after the filing with regards to starting to build in honestly the commercial structure. Just kind of what are the thoughts on timing and when that would start and the efforts that would you be employing over time before approval?

Table Of Contents

Full Year 2022 Verona Pharma PLC Earnings Call Transcript – 2023-03-07 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 7-Mar-23 2:00pm GMT

Verona Pharma PLC Corporate Call Transcript – 2022-12-20 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 20-Dec-22 8:30am GMT

Verona Pharma PLC Q3 2022 Earnings Call Transcript – 2022-11-09 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 9-Nov-22 2:00pm GMT

Verona Pharma PLC Q2 2022 Earnings Call Transcript – 2022-08-09 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 9-Aug-22 12:30pm GMT

Verona Pharma PLC KOL event for analysts and investors Call Transcript – 2022-06-16 – US$ 54.00 – Edited Transcript of VRNA.OQ conference call or presentation 16-Jun-22 12:00pm GMT

Verona Pharma PLC Q4 2021 Earnings Call Transcript – 2022-03-03 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 3-Mar-22 2:00pm GMT

Verona Pharma PLC Q3 2021 Earnings Call Transcript – 2021-11-09 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 9-Nov-21 2:00pm GMT

Verona Pharma PLC Q2 2021 Earnings Call Transcript – 2021-08-05 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 5-Aug-21 12:30pm GMT

Verona Pharma PLC Q1 2021 Earnings Call Transcript – 2021-04-29 – US$ 54.00 – Edited Transcript of VRNA.OQ earnings conference call or presentation 29-Apr-21 1:00pm GMT

Verona Pharma PLC Annual Shareholders Meeting Transcript – 2021-04-27 – US$ 54.00 – Edited Transcript of VRNA.OQ shareholder or annual meeting 27-Apr-21 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Verona Pharma PLC Q1 2022 Earnings Call Transcript" May 03, 2022. Alacra Store. May 15, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Verona-Pharma-PLC-Earnings-Call-T15182558>
  
APA:
Thomson StreetEvents. (2022). Verona Pharma PLC Q1 2022 Earnings Call Transcript May 03, 2022. New York, NY: Alacra Store. Retrieved May 15, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2022-Verona-Pharma-PLC-Earnings-Call-T15182558>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.